Dream Homes & Development Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Dream Homes & Development Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0.57	2.97	2.57	3.1	3.01	3.88	6.31	5.66	4.97	10.1
Cost of revenue	0.42	1.95	1.51	2.09	2.17	3.11	5.23	4.57	2.71	7.97
Gross profit	0.15	1.02	1.07	1.01	0.84	0.78	1.08	1.09	2.26	2.1
Selling, general and administrative	0.1	1.04	1.04	0.99	1.03	0.82	0.87	1.01	0.76	0.97
Operating expenses	0.16	1.04	1.05	1	1.04	0.83	0.87	1.02	0.76	1
Operating income	-0	-0.02	0.02	0.02	-0.2	-0.05	0.21	0.07	1.5	1.1
Interest expense	0.01			0.01	0.03	0.12	0.1	0.17	0.08	0.09
Other non-operating income	-0.01			0	-0.03	-0.12	-0.05	-0.17	-0.28	-0.27
Pre-tax income	-0.01	-0.02	0.02	0.02	-0.22	-0.17	0.15	-0.1	1.22	0.84
Income tax		0.01	0.02	0.03					0.24	0.09
Net income to minority interests									0.5	0.33
Net income	-0.01	-0.02	0	-0.01	-0.22	-0.17	0.15	-0.1	0.38	0.42
EBITDA		-0.02	0.03	0.02	-0.19	-0.04	0.21	0.08	1.5	1.13
EPS, basic	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.02	0.02
EPS, diluted	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.02	0.02
Shares, basic (weighted)	18.8	23.9	24.2	25.3	29	34.5	35.8	39.2	47.1	48.4
Shares, diluted (weighted)	18.8	23.9	24.2	25.3	29	34.5	35.8	39.2	47.1	48.4

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.27	0.24	0.12	0.23	0.05	0.19	0.53	2.71	1.05	0.9
Receivables	0.12	0.11	0.35	0.41	0.1	0.36	0.21	0.2	0.14	0.15
Inventory								0.05	7.37	4.91
Total current assets	0.44	0.43	0.57	1.02	0.2	0.81	0.99	3.3	8.56	5.96
Property, plant and equipment		0.01	0.01	0.03	0.02	0.02	0.01		0.12	0.12
Other non-current assets									0.01	0.02
Total assets	0.46	0.68	0.98	1.69	1.29	8.13	7.18	10.1	11.5	7.24
Accounts payable	0.09	0.39	0.32	0.74	0.23	0.34	0.64	0.54	1.11	0.64
Deferred revenue		0.08	0.25	0.23	0.22	0.41	0.26	0.23	0.1
Total current liabilities	0.39	0.48	0.67	1.2	0.81	5.14	5.91	3.32	5.69	3.68
Total liabilities	0.39	0.48	0.67	1.2	0.81	7.65	6.54	9.48	8.64	5.52
Paid-in capital	1.41	1.55	1.67	1.87	2.07	2.24	2.24	2.33	3.7	2.53
Retained earnings	-1.36	-1.38	-1.38	-1.4	-1.62	-1.79	-1.64	-1.73	-1.36	-1.2
Shareholders' equity	0.07	0.19	0.31	0.5	0.48	0.48	0.64	0.63	2.39	1.39
Minority interests									0.5	0.33
Total equity	0.07	0.19	0.31	0.5	0.48	0.48	0.64	0.63	2.89	1.72
Total liabilities and equity	0.46	0.68	0.98	1.69	1.29	8.13	7.18	10.1	11.5	7.24
Shares outstanding	23.7	24	24.2	25.9	31.7	31.7	35.8	40.4	47.4	48.6

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-0.01	-0.02	0	-0.01	-0.22	-0.17	0.15	-0.1	0.88	0.75
Depreciation and amortization		0	0	0.01	0.01	0.01	0	0.01	0	0.02
Stock-based compensation	0.02	0.07	0.12	0.09	0.2	0.17	0	0.09		0.03
Change in receivables	-0.12	-0.03	-0.24	-0.06	0.31	-0.26	0.18	0.01	0.06	-0.01
Change in inventory								0.2	-3.16	4.31
Change in payables	0.08	0.31	0.07	0.48	-0.5	0.21	0.41	0.02	0.33	-0.39
Cash from operations	0.26	0.11	0.03	0.23	-0.04	-0.04	0.6	0.43	-0.77	3.95
Capital expenditures		-0.01	-0.01	-0.03
Cash from investing	-0.02	-0.14	-0.16	-0.27	-0.32	-0.76	-0.02		-0.3	0.03
Stock issued		0.01
Cash from financing	0.02	0.01	0.06	0.16	0.18	0.94	-0.24	1.76	-0.59	-4.13
Net change in cash	0.26	-0.02	-0.13	0.11	-0.18	0.14	0.33	2.19	-1.66	-0.15
Free cash flow		0.11	0.02	0.2

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.03 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.9%	Gross profit / revenue.
Operating margin	11.0%	Operating income / revenue.
EBITDA margin	11.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.3%	Pre-tax income / revenue.
Net margin	4.2%	Net income / revenue.
Operating cash flow margin	39.2%	Cash from operations / revenue.
Effective tax rate	10.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	22.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.5%	Net income / average total assets.
Return on invested capital (ROIC)	108.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	9.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	102.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	16.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	27.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-7.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	24.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	20.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-26.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	75.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-24.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	75.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	11.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	39.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	0.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	87.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	-41.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	29.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	23.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-37.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	41.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	10.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	10.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.62x	Current assets / current liabilities.
Quick ratio	0.28x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	76.3%	Total liabilities / total assets.
Interest coverage	12.4x	Operating income / interest expense.
Working capital	$2.3M	Current assets - current liabilities.
Tangible book value	$1.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.07x	Revenue / average total assets.
Fixed asset turnover	86.3x	Revenue / average property, plant and equipment.
Inventory turnover	1.30x	Cost of revenue / average inventory.
Days inventory	281 days	365 x average inventory / cost of revenue.
Receivables turnover	68.9x	Revenue / average receivables.
Days sales outstanding	5 days	365 x average receivables / revenue.
Days payables	40 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	246 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.02	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.21	Revenue / diluted weighted shares.
Operating cash flow per share	$0.08	Cash from operations / diluted weighted shares.
Book value per share	$0.03	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.03	Tangible book value / shares outstanding.
Cash per share	$0.02	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.2M	Share price x shares outstanding.
Enterprise value	$343.8K	Market cap + total debt - cash - short-term investments.
P/E	2.97x	Market cap / net income. Only when net income is positive.
P/S	0.12x	Market cap / revenue.
P/B	0.90x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.90x	Market cap / tangible book value, when positive.
P/OCF	0.31x	Market cap / cash from operations, when positive.
EV/Sales	0.03x	Enterprise value / revenue.
EV/EBIT	0.31x	Enterprise value / operating income, when both are positive.
EV/EBITDA	0.30x	Enterprise value / EBITDA, when both are positive.
Earnings yield	33.6%	Net income / market cap (the inverse of P/E).

What was Dream Homes & Development Corp.'s revenue in fiscal 2025?

Dream Homes & Development Corp. reported revenue of $10.1M for fiscal 2025, 102.5% higher than the year before.

Was Dream Homes & Development Corp. profitable in fiscal 2025?

Yes. Net income was $418.3K, a net margin of 4.2%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Dream Homes & Development Corp.